Search Results

Pall Corporation, a global leader in filtration, separation and purification, continues to increase capacity to meet industry demands driven by COVID-19 with a new manufacturing facility in Spartanburg County, South Carolina and the shareholder acquisition of Pall-Austar Lifesciences Limited, a China-based joint-venture.

Pall Corporation today announced a new contract worth more than $7M with full-service contract development and manufacturing orgamization Exothera S.A.

An ongoing strategic growth plan from Cytiva and Pall Corporation, part of the Danaher Corporation, will expand manufacturing capacity and services across geographies for global life sciences customers.

Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.

Pall Corporation, a global leader in filtration, separation and purification, announced a strategic partnership with Single Use Support GmbH, a leading provider of an innovative, end-to-end solution for safe handling of biologics from bulk manufacturing to fill finish

Pall Corporation, a global leader in filtration, separation and purification, was selected by the United States Department of Defense to receive a $4.9M contract to build a new breathing filter manufacturing line within an existing U.S.-based Pall manufacturing facility to increase ventilator filter production.

Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.

Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.